Zobrazeno 1 - 7
of 7
pro vyhledávání: '"S Mejía Loza"'
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100808- (2022)
Introduction and Objectives: Clinical studies show a high prevalence of components of the metabolic syndrome (MS) in patients with liver cirrhosis not associated with NAFLD as a factor that increases portal hypertension (PH) and the frequency of vari
Externí odkaz:
https://doaj.org/article/821e7cd9451942f48eeca8179b283dc1
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100807- (2022)
Introduction and Objectives: This study aimed to determine the precipitating factors of acute kidney injury (AKI) in hospitalized patients with ACLD (Advanced chronic liver disease) Materials and methods: Retrospective, descriptive, cross-sectional s
Externí odkaz:
https://doaj.org/article/925618fad8734b33b1a46381883e3619
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100811- (2022)
Introduction and Objectives: There are few clinical studies that report the prevalence of ulcers associated with H. pylori in cirrhotic patients determined by endoscopic biopsies 5% to 20% vs. 2%-4% of the general population. The risk of ulcer bleedi
Externí odkaz:
https://doaj.org/article/789a3ca6d02c4bac86b3f212a54bf5a3
Autor:
R Chicas López, S Mejía Loza, O García Rodas, L Pinto García, F Sánchez Salinas, C Jaen Villanueva, P Guillermo, G Castañón García
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100816- (2022)
Introduction and Objectives: This study aimed to determine if there is an overlap of alcoholic hepatitis and ACLF criteria and if the presence of ACLF predicts a poor prognosis. Material and methods: Retrospective, cross-sectional, descriptive study
Externí odkaz:
https://doaj.org/article/3620992d5f9b4bf68930f01534be5f35
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100596- (2022)
Introduction and Objectives: Controlled clinical studies have demonstrated the benefits of albumin in decompensated cirrhotic patients with ascites, elevated creatinine, spontaneous bacterial peritonitis, refractory ascites, hepatorenal syndrome and
Externí odkaz:
https://doaj.org/article/18a7d32718ea4c289c72fa8a060c3759
Autor:
F- Higuera-de-la-Tijera, N.C. Flores-García, D. Kershenobich, E. Cerda-Reyes, M.S. González-Huezo, J.L. Pérez-Hernández, N. Méndez-Sánchez, O. Morales-Gutiérrez, J.E. Lira-Vera, P. Alagón-Fernández-del-Campo, F.Y. Vargas-Durán, K. Soto-Martínez, G.M.L. Guerrero-Avendaño, A. Servín-Caamaño, J.G. Gándara-Calderón, D. García-Domínguez, L.E. Díaz-Orozco, N. García-Casarreal, S. Mejía-Loza, I.B. Lázaro-Pacheco, E. Rodríguez-Fuentes
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100607- (2022)
Introduction and Objectives: If direct antiviral agents (DAA) are related to the development of HCC is controversial; therefore, exploring risk factors are crucial. We aimed to determine factors related to the development of hepatocellular carcinoma
Externí odkaz:
https://doaj.org/article/1e2c0d754dc6415186f74fb1f6d0af70
Autor:
F. Higuera-de-la-Tijera, N.C. Flores-García, D. Kershenobich, E. Cerda-Reyes, M.S. González-Huezo, J.L. Pérez-Hernández, N. Méndez-Sánchez, O. Morales-Gutiérrez, J.E. Lira-Vera, P. Alagón-Fernández-del-Campo, F.Y. Vargas-Durán, K. Soto-Martínez, G.M.L. Guerrero-Avendaño, A. Servín-Caamaño, J.G. Gándara-Calderón, D. García-Domínguez, L.E. Díaz-Orozco, N. García-Casarreal, S. Mejía-Loza, I.B. Lázaro-Pacheco, E. Rodríguez-Fuentes
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100610- (2022)
Introduction and Objectives: Clinical trials demonstrated the efficacy and safety of direct antiviral agents (DAA) to treat hepatitis C virus infection (HCV) in patients with decompensated cirrhosis (DC); however, very few real-world studies have bee
Externí odkaz:
https://doaj.org/article/f92c35d5a6d64be7bb00e91704fd7fe7